Newsfile Corp
05 Oct 2026, 21:51 UTC · 2h ago
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
Impact · against what's priced in
Ardelyx, Beta Bionics, and Aardvark Therapeutics are facing separate securities class action lawsuits. While the lawsuits introduce legal risks and potential liabilities, the current news primarily concerns procedural deadlines for lead plaintiff appointments rather than new fundamental shocks.
- ARDX−0.30
No priced-in read yet





